β-Defensin 38 serves as a crucial component of the innate immune system, playing a pivotal role in the antimicrobial defense against a diverse range of pathogens. As an antimicrobial peptide, it exerts bactericidal effects by disrupting microbial membranes and contributes to the first line of defense against infections. The activation of β-defensin 38 involves a sophisticated interplay of cellular signaling pathways influenced by various chemical activators. Compounds such as retinoic acid, thiazolidinedione, sulforaphane, butyrate, genistein, resveratrol, 5-azacytidine, alpha-lipoic acid, luteolin, diallyl disulfide, EGCG, quercetin, and curcumin contribute to the up-regulation of β-defensin 38 through distinct mechanisms. Retinoic acid directly activates β-defensin 38 by binding to retinoic acid receptors (RARs), leading to enhanced transcription. Thiazolidinediones stimulate β-defensin 38 via PPARγ activation, reinforcing the antimicrobial response. Sulforaphane activates β-defensin 38 through the Keap1-Nrf2-ARE pathway, strengthening the innate immune defense. Butyrate acts as a histone deacetylase inhibitor, promoting an open chromatin structure and elevating β-defensin 38 expression.
Genistein indirectly activates β-defensin 38 by inhibiting the PI3K/Akt pathway, influencing FoxO3a-mediated transcription. Resveratrol modulates the Nrf2/ARE pathway, enhancing β-defensin 38 expression as an antioxidant. 5-Azacytidine directly activates β-defensin 38 by demethylating the promoter region, relieving epigenetic repression. Alpha-lipoic acid activates β-defensin 38 through the Nrf2/ARE pathway, contributing to antimicrobial defense. Luteolin modulates the AP-1 pathway, alleviating negative regulation on DEFB38 expression. Diallyl disulfide influences the MAPK pathway, enhancing β-defensin 38 transcription. EGCG inhibits the NF-κB pathway, leading to increased β-defensin 38 expression. Quercetin modulates the AP-1 pathway, positively regulating β-defensin 38 synthesis. Curcumin activates β-defensin 38 through the MAPK pathway, reinforcing the antimicrobial defense mechanism. Understanding these activation mechanisms not only elucidates the intricate regulation of β-defensin 38 but also provides potential avenues for manipulating innate immunity to enhance the host's ability to combat microbial challenges.
SEE ALSO...
Items 1 to 10 of 13 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a direct activator of β-defensin 38, binds to retinoic acid receptors (RARs), forming a complex that translocates to the DEFB38 promoter. This enhances transcription, resulting in increased β-defensin 38 expression. The up-regulation contributes to innate immunity, reinforcing the antimicrobial defense against various pathogens. | ||||||
2,4-Thiazolidinedione | 2295-31-0 | sc-216281 | 50 g | $177.00 | 3 | |
Thiazolidinediones stimulate β-defensin 38 through PPARγ activation. Upon binding, PPARγ forms a complex with RXR, facilitating binding to the PPRE in the DEFB38 promoter. This enhances transcription, leading to increased β-defensin 38 expression and strengthening the innate immune response against microbial challenges. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane activates β-defensin 38 via the Keap1-Nrf2-ARE pathway. By promoting Nrf2 release from Keap1 inhibition, it facilitates Nrf2 translocation and binding to the DEFB38 promoter's ARE element. This up-regulation strengthens the antimicrobial function of β-defensin 38. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Butyrate stimulates β-defensin 38 as a histone deacetylase inhibitor. By inhibiting histone deacetylation, it promotes an open chromatin structure in the DEFB38 promoter region, facilitating increased transcription. This epigenetic modulation results in elevated β-defensin 38 expression, contributing to innate immunity against microbial threats. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein indirectly activates β-defensin 38 by inhibiting the PI3K/Akt pathway. It hinders Akt phosphorylation, relieving its inhibition on FoxO3a. This allows FoxO3a to bind to the DEFB38 promoter, promoting transcription. This indirect activation leads to increased β-defensin 38 expression, reinforcing the innate immune response against microbial challenges. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates β-defensin 38 by modulating the Nrf2/ARE pathway. Acting as an antioxidant, it enhances Nrf2 translocation, promoting its binding to the ARE element in the DEFB38 promoter. This up-regulation contributes to the antimicrobial defense mechanism of β-defensin 38. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a direct activator, promotes β-defensin 38 by demethylating the DEFB38 promoter region. By inhibiting DNA methyltransferases, it alleviates epigenetic repression, allowing for enhanced transcription. This epigenetic modulation results in increased β-defensin 38 expression, contributing to innate immunity against microbial threats. | ||||||
α-Lipoic Acid | 1077-28-7 | sc-202032 sc-202032A sc-202032B sc-202032C sc-202032D | 5 g 10 g 250 g 500 g 1 kg | $69.00 $122.00 $212.00 $380.00 $716.00 | 3 | |
Alpha-lipoic acid activates β-defensin 38 through the Nrf2/ARE pathway. As an antioxidant, it promotes Nrf2 release from Keap1 inhibition, facilitating its translocation to the DEFB38 promoter's ARE element. This up-regulation strengthens the antimicrobial function of β-defensin 38. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin stimulates β-defensin 38 by modulating the AP-1 pathway. It inhibits c-Fos and c-Jun activation, suppressing AP-1 transcriptional activity. As a consequence, the negative regulation on DEFB38 expression is alleviated, leading to increased β-defensin 38 synthesis with antimicrobial implications. | ||||||
Allyl disulfide | 2179-57-9 | sc-252359 | 25 g | $80.00 | ||
Allyl disulfide activates β-defensin 38 by influencing the MAPK pathway. It enhances ERK1/2 phosphorylation, positively regulating AP-1, which binds to the DEFB38 promoter. This leads to increased transcription of β-defensin 38, fortifying the antimicrobial defense mechanism. | ||||||